Ticker
TRAWCompany Name
TRAWS PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 6K | 0.21% | $ 2.9M |
3/31/2025 | $ 9K | 3.96% | $ 227K |
12/31/2024 | $ 12K | 5.31% | $ 226K |
9/30/2024 | $ 14K | 6.19% | $ 226K |
6/30/2024 | $ 17K | 7.52% | $ 226K |
3/31/2024 | $ 17K | 7.52% | $ 226K |
12/31/2023 | $ 16K | 7.08% | $ 226K |
9/30/2023 | $ 16K | 7.08% | $ 226K |
6/30/2023 | $ 14K | 6.19% | $ 226K |
3/31/2023 | $ 14K | 6.19% | $ 226K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor / Revenues
(=) DepAmor %
DepAmor % for TRAWS PHARMA INC is calculated as follows: DepAmor [ $ 12K ] / Revenues [ $ 204K ]
(=) DepAmor % [ 5.88% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.31K |
---|---|
min | -6.41% |
max | 22.52% |
average | 5.85% |
median | 4.22% |
std | 5.12% |